Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-24-001738

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 7, 2024 50.85M sh
Capex Q3 2024 · Sep 30, 2024 $1.24K
Capex Q3 2024 · Sep 30, 2023 $2.24K
Short Term Debt Q3 2024 · Sep 30, 2024 $134.65K
Short Term Debt Q3 2024 · Dec 31, 2023 $133.97K
Stockholders Equity Q3 2024 · Sep 30, 2024 −$251.38K
Stockholders Equity Q3 2024 · Dec 31, 2023 −$234.08K
Current Liabilities Q3 2024 · Sep 30, 2024 $304.4K
Current Liabilities Q3 2024 · Dec 31, 2023 $253.99K
Total Liabilities Q3 2024 · Sep 30, 2024 $304.4K
Total Liabilities Q3 2024 · Dec 31, 2023 $253.99K
Current Assets Q3 2024 · Sep 30, 2024 $35.27K
Current Assets Q3 2024 · Dec 31, 2023 $0
Total Assets Q3 2024 · Sep 30, 2024 $49.02K
Total Assets Q3 2024 · Dec 31, 2023 $15.93K
Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $0
Shares Diluted Q3 2024 · Sep 30, 2023 50.78M sh
Shares Diluted Q3 2024 · Sep 30, 2023 50.78M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$111.16K
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Sga Expense Q3 2024 · Sep 30, 2023 $48.38K
Sga Expense Q3 2024 · Sep 30, 2023 $203.6K
Net Income Q3 2024 · Sep 30, 2023 −$49.32K
Net Income Q3 2024 · Jun 30, 2023 −$94.71K
Net Income Q3 2024 · Mar 31, 2023 −$62.39K
Operating Income Q3 2024 · Sep 30, 2023 −$48.38K
Operating Income Q3 2024 · Sep 30, 2023 −$203.6K